Melvin Chua: Calling all ASCO members – Vote for ASCO leadership
Melvin Chua, Clinician-Scientist at the NCCS and Duke-NUS Medical School, shared a post on X by Herbert Loong, Chair-Elect of the International Affairs Committee, adding:
“In keeping with the election fever!
Calling all ASCO members – Vote for ASCO leadership.”
Quoting Herbert Loong’s post:
“Doing our bit to spread a Public Service Message Meme to all ASCO members: Make your voice heard!
Cast your votes to help shape the future of our society today!”
More posts featuring Melvin Chua and Herbert Loong.
Dr. Melvin L.K. Chua is a Clinician-Scientist at the NCCS and Duke-NUS Medical School, and Principal Investigator of the Precision Radiotherapeutics and Oncology Programme, Division of Medical Sciences, supported by the NMRC Clinician-Scientist Award. He is also the Head of Department and Senior Consultant for Head and Neck and Thoracic Cancers, Division of Radiation Oncology, and Director of the Data and Computational Science Core at the NCCS. His research is focused on phase 2-3 trials in nasopharynx (NPC) and prostate cancers (PCa).
He is also on the scientific advisory board for the NPC Guangzhou-Singapore Trial Network, a board member on the Head Neck Cancer International Group (HNCIG), and the Clinical Trials Scientific Committee Chair of HNCIG. Dr. Chuaam’s other academic activities include his present role as the Editor-in-Chief, Annals of Nasopharynx Cancer and his previous role as the Associate Senior Editor for the Head and Neck Cancer Section of the International Journal of Radiation Oncology Biology Physics – Official journal of the American Society of Radiation Oncology.
Dr. Herbert H. F. Loong is the Chair-Elect of the International Affairs Committee, a Scientific Track Member (2022-2024), and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO). Additionally, he has been promoted to Steering Committee Member at the Lung Cancer Policy Network. Dr. Loong is also the Chairperson of the Asia Pacific Coalition against Lung Cancer, a Board Member of the Connective Tissue Oncology Society, and a Committee Member of the International Association for the Study of Lung Cancer. He is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023